Recent publications
Article
Sackley, CM, Rick, C, Brady, MC, Woolley, R, Burton, C, Patel, S, Masterson-Algar, P, Nicoll, A, Smith, CH, Jowett, S, Ives, N, Beaton, G, Dickson, S, Ottridge, R, Sharp, L, Nankervis, H, Clarke, CE & PD COMM Collaborative Group 2024, 'Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson’s disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial', BMJ, vol. 386, e078341. https://doi.org/10.1136/bmj-2023-078341
Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (Courage-PD) Consortium, Domenighetti, C, Sugier, P-E, Ashok Kumar Sreelatha, A, Schulte, C, Grover, S, Mohamed, O, Portugal, B, May, P, Bobbili, DR, Radivojkov-Blagojevic, M, Lichtner, P, Singleton, AB, Hernandez, DG, Edsall, C, Mellick, GD, Zimprich, A, Pirker, W, Rogaeva, E, Lang, AE, Koks, S, Taba, P, Lesage, S, Brice, A, Corvol, J-C, Chartier-Harlin, M-C, Mutez, E, Brockmann, K, Deutschländer, AB, Hadjigeorgiou, GM, Dardiotis, E, Stefanis, L, Simitsi, AM, Valente, EM, Petrucci, S, Duga, S, Straniero, L, Zecchinelli, A, Pezzoli, G, Brighina, L, Ferrarese, C, Annesi, G, Quattrone, A, Gagliardi, M, Matsuo, H, Kawamura, Y, Hattori, N, Nishioka, K, Chung, SJ, Kim, YJ & Clarke, CE 2022, 'Dairy intake and Parkinson's disease: a mendelian randomization study', Movement Disorders, vol. 37, no. 4, pp. 857-864. https://doi.org/10.1002/mds.28902
PD Med Collaborative Group 2021, 'Cost-effectiveness of dopamine agonists and monoamine oxidase B inhibitors in early Parkinson's disease', Movement Disorders, vol. 36, no. 9, pp. 2136-2143. https://doi.org/10.1002/mds.28623
Scobie , S, Jowett, S, Lambe, T, Patel, S, Woolley, R, Rowland, N, Rick, C, Smith, C, Brady , M, Clarke, CE & Sackley, C 2021, 'Lee Silverman voice treatment versus standard speech and language therapy versus control in Parkinson’s disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial', Pilot and Feasibility Studies, vol. 7, no. 1, 154. https://doi.org/10.1186/s40814-021-00888-y
Gray, R, Patel, S, Rowland, N, Rick, C, Woolley, R, Muzerengi, S, Gray, A, Jenkinson, C, McIntosh, E, Wheatley, K, Williams, A, Clarke, CE & PD Med Collaborative Group 2021, 'Long-term effectiveness of adjuvant treatment with catechol-O-methyltransferase or monoamine oxidase B inhibitors compared with dopamine agonists among patients with Parkinson disease uncontrolled by Levodopa Therapy: the PD MED randomized clinical trial', JAMA Neurology. https://doi.org/10.1001/jamaneurol.2021.4736
Comprehensive Unbiaised Risk Factor Assessment for Genetics and Environment in Parkinson’s Disease (Courage-PD) consortium 2021, 'Mendelian randomisation study of smoking, alcohol, and coffee drinking in relation to Parkinson's disease', Journal of Parkinson's Disease. https://doi.org/10.3233/JPD-212851
Sackley, C, Rick, C, Au, P, Brady , MC, Beaton , G, Burton, C, Caulfield, M, Dickson , S, Dowling, F, Hughes, M, Rowland, N, Jowett, S, Masterson-Algar, P, Nicoll , A, Patel, S, Smith , CH, Woolley, R & Clarke, CE 2020, 'A multi-centre randomised controlled trial to compare the clinical and cost effectiveness of Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial', Trials, vol. 21, no. 1, 436. https://doi.org/10.1186/s13063-020-04354-7
Lang, AE, de Bie, RMA, Clarke, CE, Espay, AJ & Fox, SH 2020, 'Initiating pharmacotherapy in early Parkinson's disease', The Lancet Neurology, vol. 19, no. 8, pp. 643-644. https://doi.org/10.1016/S1474-4422(20)30225-8
Herd, C, Tomlinson, C, Rick, C, Scotton, W, Edwards, J, Ives, N, Clarke, CE & Sinclair, A 2019, 'Cochrane systematic review and meta-analysis of Botulinum toxin for the prevention of migraine', BMJ open, vol. 9, no. 7, e027953. https://doi.org/10.1136/bmjopen-2018-027953
Smith, CH, Patel, S, Woolley, RL, Brady, MC, Rick, CE, Halfpenny, R, Rontiris, A, Knox-Smith, L, Dowling, F, Clarke, CE, Au, P, Ives, N, Wheatley, K & Sackley, CM 2019, 'Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listeners', Clinical Linguistics & Phonetics, vol. 33, no. 10-11, pp. 1063-1070. https://doi.org/10.1080/02699206.2019.1604806
American Genome Center 2019, 'The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight', Movement Disorders, vol. 34, no. 12, pp. 1851-1863. https://doi.org/10.1002/mds.27864
Herd, C, Cl, T, Rick, C, Scotton, WJ, Edwards, J, Ives, N, Clarke, CE & Sinclair, A 2018, 'Botulinum toxins for the prevention of migraine in adults', Cochrane Database of Systematic Reviews, no. 6, CD011616. https://doi.org/10.1002/14651858.CD011616.pub2
Review article
Carroll, C, Clarke, CE, Grosset, D, Rather, A, Mohamed, B, Parry, M, Reddy, P, Fackrell, R & Chaudhuri, KR 2024, 'Addressing Comorbidities in People with Parkinson’s Disease: Considerations From An Expert Panel', Journal of Parkinson's Disease, vol. 14, no. 1, pp. 53-63. https://doi.org/10.3233/jpd-230168
de Bie, RMA, Clarke, CE, Espay, AJ, Fox, SH & Lang, AE 2020, 'Initiation of pharmacological therapy in Parkinson's disease: when, why, and how', The Lancet Neurology, vol. 19, no. 5, pp. 452-461. https://doi.org/10.1016/S1474-4422(20)30036-3
Herd, CP, Tomlinson, CL, Rick, C, Scotton, WJ, Edwards, J, Ives, N, Clarke, CE & Sinclair, A 2018, 'Botulinum toxins for the prevention of migraine in adults', Cochrane Database of Systematic Reviews, vol. 6, CD011616. https://doi.org/10.1002/14651858.CD011616.pub2
View all publications in research portal